Cited by 1,821Electroconvulsive Therapy StudiesPoisoning and overdose treatmentsPharmacovigilance and Adverse Drug Reactions

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

The Serotonin Syndrome

Boyer, Edward W., Shannon, Michael·2005·New England Journal of Medicine

DOI 10.1056/nejmra041867

Open this paper in CoChat — free account

Abstract

The serotonin syndrome is a potentially life-threatening drug reaction that may result from therapeutic medication use, self-poisoning, or interactions between drugs.

Integrity signals

Registry

Crossref · 10.1056/nejmra041867

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025
The serotonin syndrome
Sternbach, H. A. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.6.705 · Cited by 1,349
The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity
Dunkley, E. J. C., Isbister, G. K., Sibbritt, D. W., Dawson, A. H., & Whyte, I. M. (2003) · QJM · doi:10.1093/qjmed/hcg109 · Cited by 1,032
Neuroleptic malignant syndrome
Levenson, J. L. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.10.1137 · Cited by 984
2002 annual report of the American association of poison control centers toxic exposure surveillance system
Watson, W. A., Litovitz, T. L., Rodgers, G. C., Klein‐Schwartz, W., Youniss, J., Rose, S. R., Borys, D. J., & May, M. E. (2003) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(03)00088-3 · Cited by 481
Interactions Between Herbal Medicines and Prescribed Drugs
Izzo, A., & Ernst, E. (2012) · Drugs · doi:10.2165/00003495-200161150-00002 · Cited by 464
Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose
Isbister, G. K., Bowe, S. J., Dawson, A. H., & Whyte, I. M. (2004) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120037428 · Cited by 432
The Libby Zion Case
Asch, D. A., & Parker, R. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181209 · Cited by 396
Effects of Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy on Serotonergic Symptoms in Newborns and Cord Blood Monoamine and Prolactin Concentrations
Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. O. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.720 · Cited by 329
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity
Parrott, A. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00711-0 · Cited by 325

Flagged first, then by citations

Show all 49 references

Research works printed but not linked: 8

Sampson E, 1999, Br J Gen Pract, 49, 867
Mackay FJ, 1999, Br J Gen Pract, 49, 871
Hoyer D, 1994, Pharmacol Rev, 46, 157
Saper CB. Brain stem modulation of sensation, movement, and consciousness. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of neural science. 4th ed. New York: McGraw-Hill, 2000:896.
Kline SS, 1989, Clin Pharm, 8, 510
Whyte I, 2002, J Toxicol Clin Toxicol, 40, 668
Boddy R, 2004, J Toxicol Clin Toxicol, 42, 725
Olsen D, 2004, J Toxicol Clin Toxicol, 42, 744

Sorted by citations

Items 201–300 of 1,000

Role of physical activity and diet on mood, behavior, and cognition
Strasser, B., & Fuchs, D. (2015) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2015.07.002 · Cited by 63
An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as “bath salts”
López‐Arnau, R., Martínez-Clemente, J., Carbó, M., Pubill, D., Escubedo, E., & Camarasa, J. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.007 · Cited by 57
Use of Serotonergic Drugs and the Risk of Bleeding
Verdel, B. M., Souverein, P. C., Meenks, S. D., Heerdink, E. R., Leufkens, H. G. M., & Egberts, T. C. G. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.240 · Cited by 57
Drugs of Abuse: The Highs and Lows of Altered Mental States in the Emergency Department
Meehan, T. J., Bryant, S. M., & Aks, S. E. (2010) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2010.03.012 · Cited by 56
Novel psychoactive substances: identifying and managing acute and chronic harmful use
Tracy, D. K., Wood, D. M., & Baumeister, D. (2017) · BMJ · doi:10.1136/bmj.i6814 · Cited by 56
Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review
Monte, A. A., Chuang, R., & Bodmer, M. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03747.x · Cited by 56
The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the hamilton rating scales
Sugarman, M. A., Loree, A. M., Baltes, B. B., Grekin, E. R., & Kirsch, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106337 · Cited by 55
Parathyroid surgery and methylene blue: A review with guidelines for safe intraoperative use
Pollack, G., Pollack, A. Z., Delfiner, J., & Fernandez, J. (2009) · The Laryngoscope · doi:10.1002/lary.20581 · Cited by 55
Serotonin Syndrome Induced by Fluvoxamine and Oxycodone
Karunatilake, H., & Buckley, N. A. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e671 · Cited by 55
A Systematic Review on Drug Interactions in Oncology
Riechelmann, R. P., & Saad, E. D. (2006) · Cancer Investigation · doi:10.1080/07357900601063766 · Cited by 55
MDR Tuberculosis Treatment
Pereiro, J. E., Sánchez‐Montalvá, A., Aznar, M. L., & Espiau, M. (2022) · Medicina · doi:10.3390/medicina58020188 · Cited by 60
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive‐like behaviour in the WAG / R ij rat model of absence epilepsy
Citraro, R., Leo, A., Fazio, P. D., Sarro, G. D., & Russo, E. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13121 · Cited by 54
Serotonergic and Adrenergic Drug Interactions Associated with Linezolid: A Critical Review and Practical Management Approach
Ramsey, T., Lau, T. T. Y., & Ensom, M. H. H. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r604 · Cited by 54
Adverse drug reactions resulting in hyperthermia in the intensive care unit
McAllen, K. J., & Schwartz, D. R. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181dda0d4 · Cited by 53
Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens
Grgurich, P. E., Hudcova, J., Lei, Y., Sarwar, A., & Craven, D. E. (2012) · Expert Review of Respiratory Medicine · doi:10.1586/ers.12.45 · Cited by 55
Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art.
Rapaport, M. H. (2007) · PubMed · Cited by 53
Combining antidepressants: a review of evidence
Palaniyappan, L. K., Insole, L., & Ferrier, N. (2009) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.107.004820 · Cited by 53
Serotonin induces melanogenesis via serotonin receptor 2A
Lee, H. J., Park, M. K., Kim, S. Y., Choo, H. Y. P., Lee, A. Y., & Lee, C.-H. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10490.x · Cited by 52
MDAI (5,6‐methylenedioxy‐2‐aminoindane; 6,7‐dihydro‐5H‐cyclopenta[f][1,3]benzodioxol‐6‐amine; ‘sparkle’; ‘mindy’) toxicity: a brief overview and update
Corkery, J., Elliott, S. P., Schifano, F., Corazza, O., & Ghodse, A. H. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2298 · Cited by 52
Risk of Death Related to Psychotropic Drug Use in Older People During the European 2003 Heatwave: A Population-Based Case–Control Study
Nordon, C., Martin‐Latry, K., de Roquefeuil, L., Latry, P., Bégaud, B., Falissard, B., Rouillon, F., & Verdoux, H. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181b7ef6e · Cited by 53
Hospitalist Perspective on the Treatment of Skin and Soft Tissue Infections
Amin, A., Cerceo, E. A., Deitelzweig, S. B., Pile, J. C., Rosenberg, D. J., & Sherman, B. M. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.04.018 · Cited by 55
Bench-to-bedside review: Mechanisms and management of hyperthermia due to toxicity
Eyer, F., & Zilker, T. R. (2007) · Critical Care · doi:10.1186/cc6177 · Cited by 52
The present and future of opioid analgesics in small animal practice
Simon, B. T., & Steagall, P. V. M. (2016) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12377 · Cited by 52
Neuroleptic Malignant Syndrome
Wijdicks, E. F. M., & Ropper, A. H. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2404606 · Cited by 51
Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug–drug interactions
Rietjens, S. J., Hondebrink, L., Westerink, R. H. S., & Meulenbelt, J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.725029 · Cited by 53
Emergencies and critical issues in Parkinson’s disease
Simonet, C., TOLOSA, E. S., Cámara, A., & Valldeoriola, F. (2019) · Practical Neurology · doi:10.1136/practneurol-2018-002075 · Cited by 51
Relationship of presympathetic‐premotor neurons to the serotonergic transmitter system in the rat brainstem
Kerman, I. A., Shabrang, C., Taylor, L. P., Akil, H., & Watson, S. J. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21129 · Cited by 51
Serotonin syndrome following methylene blue infusion during parathyroidectomy: A case report and literature review
Ng, B., Cameron, A. J. D., Liang, R., & Rahman, H. U. (2008) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03017595 · Cited by 51
Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study ( STACCATO )
Panisset, M., Chen, J. J., Rhyee, S. H., Conner, J. B., Mathena, J., & the STACCATO study investigators (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1500 · Cited by 50
Linking Pharmacology to Clinical Reports: Cyclobenzaprine and Its Possible Association With Serotonin Syndrome
Mestres, J., Seifert, S. A., & Oprea, T. I. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.177 · Cited by 50
Medication Pain Management in the Elderly: Unique and Underutilized Analgesic Treatment Options
Atkinson, T. J., Fudin, J., Pandula, A., & Mirza, M. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.09.008 · Cited by 50
Drug-Induced Serotonin Syndrome
Bartlett, D. (2017) · Critical Care Nurse · doi:10.4037/ccn2017169 · Cited by 50
Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis
Gatti, M., Raschi, E., & Ponti, F. D. (2020) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-02990-1 · Cited by 50
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review
Schifano, F., Chiappini, S., Miuli, A., Corkery, J., Scherbaum, N., Napoletano, F., Arillotta, D., Zangani, C., Catalani, V., Vento, A. E., et al. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113638 · Cited by 50
Methylenedioxymethamphetamine (ecstasy)-related hyperthermia
Patel, M. M., Belson, M. G., Longwater, A. B., Olson, K. R., & Miller, M. A. (2005) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2005.05.007 · Cited by 49
Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications
Halpern, B., & Halpern, A. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.994502 · Cited by 51
Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary
Dosi, R., Ambaliya, A., Joshi, H. K., & Patell, R. D. (2014) · BMJ Case Reports · doi:10.1136/bcr-2014-204154 · Cited by 49
A New Look at the Neonate's Clinical Presentation After In Utero Exposure to Antidepressants in Late Pregnancy
Boucher, N., Bairam, A., & Beaulac-Baillargeon, L. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318173aa2e · Cited by 49
Serotonin Syndrome in a Chronic-Pain Patient Receiving Concurrent Methadone, Ciprofloxacin, and Venlafaxine
Lee, J., Franz, L., & Goforth, H. W. (2009) · Psychosomatics · doi:10.1016/s0033-3182(09)70868-0 · Cited by 48
Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia
Wallace, C., GALLOWAY, T., McKetin, R., Kelly, E. V., & LEARY, J. (2009) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2008.00016.x · Cited by 48
High risk and low prevalence diseases: Serotonin syndrome
Spadaro, A., Scott, K. R., Koyfman, A., & Long, B. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.08.030 · Cited by 47
Deaths involving serotonergic drugs
Pilgrim, J. L., Gerostamoulos, D., & Drummer, O. H. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2010.01.014 · Cited by 47
Toxicology in the ICU
Levine, M., Brooks, D. E., Truitt, C. A., Wolk, B., Boyer, E. W., & Ruha, A. (2011) · CHEST Journal · doi:10.1378/chest.10-2548 · Cited by 47
Self-citation
A Critical Evaluation of Reports Associating Ayahuasca with Life-Threatening Adverse Reactions
SANTOS, R. G. D. (2013) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.785846 · Cited by 50
Movement disorders induced by psychiatric drugs that do not block dopamine receptors
Friedman, J. H. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.08.031 · Cited by 47
Fatal serotonin syndrome: a systematic review of 56 cases in the literature
Prakash, S., Rathore, C., Rana, K., & Prakash, A. (2020) · Clinical Toxicology · doi:10.1080/15563650.2020.1839662 · Cited by 47
Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics
Rudin, D., Liechti, M. E., & Luethi, D. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113778 · Cited by 49
Side effect profile of 5‐ HT treatments for P arkinson's disease and L ‐ DOPA ‐induced dyskinesia in rats
Lindenbach, D., Palumbo, N. E., Ostock, C. Y., Vilceus, N., Conti, M. M., & Bishop, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12894 · Cited by 47
Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances.
Abdulrahim, D., & Bowden‐Jones, O. (2015) · Cited by 46
Serotonin Syndrome Associated with Triptan Monotherapy
Soldin, O. P., & Tonning, J. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0706410 · Cited by 46
Changes in animal activity prior to a major (M= 7) earthquake in the Peruvian Andes
Grant, R., Raulin, J., & Freund, F. (2015) · Physics and Chemistry of the Earth Parts A/B/C · doi:10.1016/j.pce.2015.02.012 · Cited by 46
Movement disorders emergencies: a review
Munhoz, R. P., Moscovich, M., Araujo, P. D., & Teive, H. A. G. (2012) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2012000600013 · Cited by 46
Anesthetic Considerations for Patients on Antidepressant Therapy—Part I
Saraghi, M., Golden, L. R., & Hersh, E. V. (2017) · Anesthesia Progress · doi:10.2344/anpr-64-04-14 · Cited by 46
Psychotropic drug therapy in patients in the intensive care unit - usage, adverse effects and drug interactions: a review
Shafiekhani, M., Mirjalili, M., & Vazin, A. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s176079 · Cited by 44
Methylene Blue Application to Lessen Pain: Its Analgesic Effect and Mechanism
Lee, S. W., & Han, H. C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.663650 · Cited by 43
Tedizolid Phosphate for the Management of Acute Bacterial Skin and Skin Structure Infections: Safety Summary
Das, D., Tulkens, P. M., Mehra, P., Fang, E., & Prokocimer, P. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit618 · Cited by 45
Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data
Butterfield, J. M., Lawrence, K. R., Reisman, A. L., Huang, D. B., Thompson, C. A. H., & Lodise, T. P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr467 · Cited by 45
The pharmacological interaction of compounds in ayahuasca: a systematic review
Ruffell, S., Netzband, N., Bird, C., Young, A. H., & Juruena, M. F. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-0884 · Cited by 57
Serotonin toxicity involving MDMA (ecstasy) and moclobemide
Pilgrim, J. L., Gerostamoulos, D., Woodford, N. W. F., & Drummer, O. H. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2011.04.008 · Cited by 45
Mechanisms of Neurologic Failure in Critical Illness
Pustavoitau, A., & Stevens, R. D. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2007.11.004 · Cited by 45
Serotonin Syndrome in Dextromethorphan Ingestion Responsive to Propofol Therapy
Ganetsky, M., Babu, K. M., & Boyer, E. W. (2007) · Pediatric Emergency Care · doi:10.1097/pec.0b013e31815a0667 · Cited by 44
Self-citation
Serotonin Syndrome from the Interaction of Cyclobenzaprine with Other Serotoninergic Drugs
Keegan, M. T., Brown, D., & Rabinstein, A. A. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000247699.81580.eb · Cited by 44
Qualitative Research of Online Drug Misuse Communities with Reference to the Novel Psychoactive Substances
Jebadurai, J. K. (2013) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.18745/th.11352 · Cited by 44
Potential use of ayahuasca in grief therapy
González, D., Carvalho, M., Cantillo, J., Aixalá, M., & Farré, M. (2019) · OMEGA - Journal of Death and Dying · doi:10.1177/0030222817710879 · Cited by 44
Assessment and Management of Toxidromes in the Critical Care Unit
Rasimas, J. J., & Sinclair, C. M. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.03.002 · Cited by 43
Lithium and venlafaxine interaction: a case of serotonin syndrome
Adán-Manes, J., Novalbos, J., López‐Rodríguez, R., Ayuso‐Mateos, J. L., & Abad‐Santos, F. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00745.x · Cited by 43
Serotonin Syndrome after Concomitant Treatment with Linezolid and Meperidine
Das, P. K., Warkentin, D. I., Hewko, R., & Forrest, D. L. (2007) · Clinical Infectious Diseases · doi:10.1086/524671 · Cited by 43
SSRI and Motor Recovery in Stroke: Reestablishment of Inhibitory Neural Network Tonus
Pinto, C. B., Vélez, F. G. S., Lopes, F., Piza, P. V. D. T., Dipietro, L., Wang, Q. M., Mazwi, N., Camargo, E. C., Black‐Schaffer, R. M., & Fregni, F. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00637 · Cited by 45
A Systematic Approach to the Treatment of Vasoplegia Based on Recent Advances in Pharmacotherapy
Ortoleva, J. P., & Cobey, F. C. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.11.025 · Cited by 44
Use of Psychotropic Medications Among Youth in Treatment Foster Care
Brenner, S. L., Southerland, D. G., Burns, B. J., Wagner, H. R., & Farmer, E. M. Z. (2013) · Journal of Child and Family Studies · doi:10.1007/s10826-013-9882-3 · Cited by 42
Maternal Use of Venlafaxine Near Term: Correlation Between Neonatal Effects and Plasma Concentrations
Boucher, N., Koren, G., & Beaulac-Baillargeon, L. (2009) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181a58fb4 · Cited by 42
Risk of caffeine toxicity associated with the use of ‘legal highs’ (novel psychoactive substances)
Davies, S., Lee, T., Ramsey, J., Dargan, P. I., & Wood, D. M. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1144-y · Cited by 42
Deaths involving contraindicated and inappropriate combinations of serotonergic drugs
Schumann, J., Gerostamoulos, D., & Drummer, O. H. (2010) · International Journal of Legal Medicine · doi:10.1007/s00414-010-0536-3 · Cited by 42
The link between autism spectrum disorder and gut microbiota: A scoping review
Nitschke, A. S., Deonandan, R., & Konkle, A. T. M. (2020) · Autism · doi:10.1177/1362361320913364 · Cited by 46
The Microbiome in Health and Disease from the Perspective of Modern Medicine and Ayurveda
Wallace, R. K. (2020) · Medicina · doi:10.3390/medicina56090462 · Cited by 47
What is healthcare-associated pneumonia, and how should it be treated?
Craven, D. E. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000216626.05821.40 · Cited by 42
Treatment of four psychiatric emergencies in the intensive care unit
Sevransky, J., Bienvenu, O. J., Neufeld, K. J., & Needham, D. M. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825ae0f8 · Cited by 41
Serotonin Syndrome and Rhabdomyolysis Induced by Concomitant Use of Triptans, Fluoxetine and Hypericum
Bonetto, N., Santelli, L., Battistin, L., & Cagnin, A. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01430.x · Cited by 41
Characterizing the differential roles of striatal 5-HT 1A auto- and hetero-receptors in the reduction of l -DOPA-induced dyskinesia
Meadows, S. M., Chambers, N., Conti, M. M., Bossert, S. C., Tasber, C., Sheena, E., Varney, M. A., Newman‐Tancredi, A., & Bishop, C. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.03.013 · Cited by 41
An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control System
Nguyen, H. T., Pan, A., Smollin, C. G., Cantrell, L. F., & Kearney, T. (2019) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12796 · Cited by 41
Movement Disorders Emergencies
Rajan, S. M., Kaas, B. M., & Moukheiber, E. S. (2019) · Seminars in Neurology · doi:10.1055/s-0038-1677050 · Cited by 41
Clinically relevant drug interactions in anxiety disorders
Muscatello, M. R. A., Spina, E., Bandelow, B., & Baldwin, D. S. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2217 · Cited by 41
Diagnosing and managing migraine headache.
Mueller, L. (2007) · PubMed · Cited by 41
Atypical Neuroleptic Malignant Syndrome or Serotonin Toxicity Associated with Atypical Antipsychotics?
Odagaki, Y. (2009) · Current Drug Safety · doi:10.2174/157488609787354387 · Cited by 41
Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse
Carmo, H., Hengstler, J. G., de Boer, D., Ringel, M. T., Carvalho, F. D., Fernandes, E. G. R., Remião, F., dos Reys, L. A., Oesch, F., & Bastos, M. D. L. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0850-0 · Cited by 41
Effects of opioids on human serotonin transporters
Barann, M., Stamer, U. M., Lyutenska, M., Stüber, F., Bönisch, H., & Urban, B. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1056-3 · Cited by 41
Bench-to-bedside review: critical illness-associated cognitive dysfunction--mechanisms, markers, and emerging therapeutics.
Milbrandt, E. B., & Angus, D. C. (2006) · Critical Care · doi:10.1186/cc5078 · Cited by 41
Linezolid-associated serotonin syndrome: what we can learn from cases reported so far
Morales-Molina, J. A., Antonio, J. M.-D., Marín-Casino, M., & Grau, S. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki368 · Cited by 41
A case of serotonin syndrome precipitated by fentanyl and ondansetron in a patient receiving paroxetine, duloxetine, and bupropion
Gollapudy, S., Kumar, V., & Dhamee, M. S. (2012) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2011.04.017 · Cited by 40
Identifying and Managing Sources of Pain and Distress in Children with Neurological Impairment
Hauer, J. (2010) · Pediatric Annals · doi:10.3928/00904481-20100318-04 · Cited by 40
Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems
Thomas, M. A., Joshi, P. P., & Klaper, R. D. (2011) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2011.05.014 · Cited by 44
Serotonin Is a Key Factor for Mouse Red Blood Cell Survival
Amireault, P., Bayard, E., Launay, J., Sibon, D., Kim, C. L. V., Colin, Y., Dy, M., Hermine, O., & Côté, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083010 · Cited by 42
Anesthetic implications of recreational drug use
Beaulieu, P. (2017) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-017-0975-0 · Cited by 40
Controversies in Serotonin Syndrome Diagnosis and Management: A Review
Uddin, M. F. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/29473.10696 · Cited by 40
Serotonergic targets for the treatment of l-DOPA-induced dyskinesia
Lanza, K., & Bishop, C. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-017-1837-1 · Cited by 40
Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques
Ott, M., Mannchen, J. K., Jamshidi, F., & Werneke, U. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125318818814 · Cited by 40
Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe
Miliano, C., Marti, M., Pintori, N., Castelli, M. P., Tirri, M., Arfè, R., & Luca, M. A. D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01406 · Cited by 40
Antiepileptic drugs and serotonin syndrome- A systematic review of case series and case reports
Prakash, S., Rathore, C., Rana, K., & Patel, H. D. (2021) · Seizure · doi:10.1016/j.seizure.2021.06.004 · Cited by 40
Visual Trails: Do the Doors of Perception Open Periodically?
Dubois, J., & Rufin Vanrullen, A. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001056 · Cited by 40
Neuroleptic Malignant Syndrome and Serotonin Syndrome in the Critical Care Setting: Case Analysis
Kaufman, K. R., Levitt, M. J., Schiltz, J. F., & Sunderram, J. (2006) · Annals of Clinical Psychiatry · doi:10.1080/10401230600801259 · Cited by 40

Authors: Boyer, E. W., & Shannon, M.
Affiliations: Boston Children's Hospital (US)
ORCID: Boyer, Edward W.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2005-03-17
Volume: 352
Issue: 11
Pages: 1112-1120
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra041867
OpenAlex: W2123778879
Cited by: 1,821
References: 49
Citations by year: 2026: 47 · 2025: 65 · 2024: 84 · 2023: 53 · 2022: 78 · 2021: 74 · 2020: 92 · 2019: 86 · 2018: 99 · 2017: 96 · 2016: 98 · 2015: 112 · 2014: 121 · 2013: 109 · 2012: 93
FWCI: 11.96
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA14929, R21DA014929)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords: serotonin syndrome, adverse drug reactions, drug interactions, self-poisoning, serotonin receptor agonists
MeSH terms: Algorithms, Antidepressive Agents, Diagnostic Errors, Drug Interactions, Humans, Monoamine Oxidase Inhibitors, Selective Serotonin Reuptake Inhibitors, Serotonin Syndrome, Drug Overdose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Serotonin Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks